Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Ethnopharmacol ; 271: 113805, 2021 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-33465442

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Syzygium cumini (L.) Skeels is an important medicinal plant utilized in the health care systems of Pakistan, India, Sri Lanka, and Bangladesh. S. cumini have been used to treat renal issues, indigestion, diabetes, dysentery, and employed in folk medicine to treat inflammations. It is known to anticipate antioxidant, anti-inflammatory, anticancer, anti-diabetic, anti-bacterial, antifungal, activities, and radioprotective activities. MATERIAL AND METHODS: We examined the in vitro anti-inflammatory activities of S. cumini fruit extracts, evaluated using membrane stabilization, egg albumin denaturation, and bovine serum albumin denaturation assays. In vivo anti-inflammatory activity was also assessed, using murine models of carrageenan, formaldehyde, and PGE2 induced paw edema. Fractionation of active extracts was performed using HPLC, followed by LC-ESI-MS/MS analysis to identify the bioactive compounds responsible for anti-inflammatory activity. RESULTS: The crude methanolic extract showed stronger in vitro and in vivo anti-inflammatory activities compared to other extracts. The most potent effects were observed in the formaldehyde induced paw edema assay wherein methanolic extract and standard indomethacin induced 72% and 88% inhibition against paw edema volume in comparison to control (normal saline) respectively. In the bovine serum albumin denaturation assay the methanolic extract induced 82% inhibition against denaturation as compared to control (phosphate buffer) while standard diclofenac sodium induced 98% inhibition. In contrast, 50% v/v MeOH:H2O or 100% dichloromethane extracts displayed moderate to weak effects in the anti-inflammatory models. HPLC fractionation provided 6 active sub-fractions, four (MF2, MF3, MF6, MF7) from the 100% methanolic extract and two (HAF1, HAF3) from the 50% methanolic extract. The MF2, MF7, and HAF1 sub-fractions displayed potent activity in all studied in vitro assays. LC-ESI-MS-MS analysis tentatively identified delphinidin 3-glucoside, peonidin-3,5-diglucoside, gallic acid, liquitrigenin, scopoletin, umbelliferon, and rosmanol from the 100% methanolic fractions. Myricetin, catechin, quinic acid, chlorogenic acid, ellagic acid, gallic acid, and caffeic acid were identified in the 50% methanolic fractions. CONCLUSIONS: These results demonstrate that S. cumini fruit extracts are a rich source of bioactive compounds that are worthy of further investigation as leads for anti-inflammatory drug discovery.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Edema/tratamiento farmacológico , Extractos Vegetales/farmacología , Syzygium/química , Animales , Antiinflamatorios/química , Antiinflamatorios/uso terapéutico , Antioxidantes/química , Antioxidantes/uso terapéutico , Asia , Modelos Animales de Enfermedad , Edema/inducido químicamente , Traumatismos de los Pies/inducido químicamente , Traumatismos de los Pies/tratamiento farmacológico , Traumatismos de los Pies/patología , Frutas/química , Técnicas In Vitro , Medicina Tradicional , Ratones , Fitoquímicos/análisis , Fitoquímicos/química , Extractos Vegetales/uso terapéutico , Ratas Wistar
2.
Pediatr Emerg Care ; 35(12): e234-e235, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30702643

RESUMEN

We present an illustrative case of unintentional burns to the feet of a 15-month-old child following the application of raw garlic as a home remedy for fever. We provide an overview of the historical medicinal uses of garlic as well as its unintended adverse effects. This case underscores the importance of clinicians' ability to recognize unusual presentations of injury due to culturally based practices that require care in emergency settings. This is particularly important in patient populations for whom abusive etiology would be considered.


Asunto(s)
Quemaduras Químicas/patología , Fiebre/terapia , Traumatismos de los Pies/inducido químicamente , Ajo/efectos adversos , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Bacitracina/administración & dosificación , Bacitracina/uso terapéutico , Vendajes/normas , Quemaduras Químicas/tratamiento farmacológico , Quemaduras Químicas/etiología , Femenino , Fiebre/complicaciones , Traumatismos de los Pies/patología , Humanos , Lactante , Medicina Tradicional/efectos adversos , Fenoles/administración & dosificación , Resultado del Tratamiento
6.
J Oncol Pharm Pract ; 12(3): 131-41, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17022868

RESUMEN

INTRODUCTION: Capecitabine (Xeloda) is a systemic prodrug of 5-fluorouracil (5-FU), which is administered in an oral formulation. Hand-foot syndrome (HFS) has proven to be a chronic dose-limiting toxicity of capecitabine, leading to significant morbidity in patients receiving this agent. The purpose of this review is to define the pathophysiology, risk factors, incidence and management of capecitabine-induced HFS. METHODS: Literature for this review article was collected from the following databases: PubMed, CINAHL, and the proceedings of the American Society of Clinical Oncology (ASCO) confined to the years 1995-2006. The following key terms were used in the search: hand-foot syndrome, palmar-plantar erythrodysesthesia, capecitabine, Xeloda, colorectal cancer, and metastatic breast cancer. RESULTS: HFS associated with capecitabine is a serious dose-limiting toxicity. Incidence of grade 3/4 toxicity is of extreme significance, and introduces the need for dose reductions and/or interruptions in capecitabine therapy. Drug-related therapies studied include topical emollients and creams, systemic and topical corticosteroids, nicotine patch, vitamin E, pyridoxine, and COX-2 inhibitors. However, due to the lack of randomized, controlled trials with these therapies, the current mainstay of treatment for the management of this toxicity is interruption of therapy and, if necessary, dose reduction. CONCLUSION: Treatment interruption or dose reduction remain the only methods shown to effectively manage HFS, but supportive measures to reduce pain and discomfort and prevent secondary infection are very important. Many other prophylactic and treatment strategies have been investigated, with pyridoxine and COX-2 inhibitors being the most promising in case reports and retrospective studies; therefore, prospective, randomized, controlled trials are needed to prove their efficacy.


Asunto(s)
Antimetabolitos Antineoplásicos/efectos adversos , Desoxicitidina/análogos & derivados , Fluorouracilo/análogos & derivados , Parestesia/inducido químicamente , Antimetabolitos Antineoplásicos/uso terapéutico , Capecitabina , Desoxicitidina/efectos adversos , Fluorouracilo/efectos adversos , Traumatismos de los Pies/inducido químicamente , Traumatismos de los Pies/patología , Traumatismos de la Mano/inducido químicamente , Traumatismos de la Mano/patología , Humanos , Síndrome
7.
Immunopharmacol Immunotoxicol ; 28(3): 397-410, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16997789

RESUMEN

This study was aimed to evaluate the therapeutic potency of a new antimalarial drug, artesunate, in an experimental model of rheumatoid arthritis. Collagen-induced arthritis (CIA) was induced in Lewis rats.The intraperitoneally administration of artesunate (ARS) and methotrexate (MTX) were started on day 25 postimmunization and continued until final assessment on day 35. During this period, clinical examination was intermittent. The anticollagen type II antibody (CII Ab) and nitric oxide synthesis were measured. The paws and kness were then removed for histopathology and radiography assay. The biocompatibility of ARS and MTX were assessed using fibrosarcoma cell line. Our results showed that i.p. injection of artesunate to arthritic rats induced a significant reduction in paw edema. This beneficial effect was associated with a significant decrease in anti-CII antibody response compared with untreated rats. Histopathological assessment showed reduced inflammatory cells infiltrate in joints of treated rats, and tissue edema and bone erosion in the paws were markedly reduced following ARS therapy. Moreover, our radiographic results paralleled histological findings. Cytotoxicity analysis of ARS showed greater tolerability compared with MTX. Treatment with ARS significantly diminished nitric oxide formation in treated rats compared with untreated controls. Our findings revealed the therapeutic efficacy of artesunate in experimental rheumatoid arthritis compared with a choice drug (methotrexate). This result may recommend it as a second-line drug in the treatment of rheumatoid arthritis.


Asunto(s)
Artemisininas/uso terapéutico , Artritis Experimental/tratamiento farmacológico , Sesquiterpenos/uso terapéutico , Animales , Artemisininas/administración & dosificación , Artesunato , Artritis Experimental/inmunología , Artritis Experimental/metabolismo , Autoanticuerpos/análisis , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Colágeno Tipo II/inmunología , Colagenasas/metabolismo , Edema/inducido químicamente , Edema/tratamiento farmacológico , Edema/inmunología , Traumatismos de los Pies/inducido químicamente , Traumatismos de los Pies/tratamiento farmacológico , Traumatismos de los Pies/inmunología , Miembro Posterior/diagnóstico por imagen , Miembro Posterior/lesiones , Miembro Posterior/ultraestructura , Humanos , Inflamación/inducido químicamente , Inflamación/inmunología , Inflamación/patología , Inyecciones Intradérmicas , Inyecciones Intraperitoneales , Masculino , Inhibidores de la Metaloproteinasa de la Matriz , Metotrexato/administración & dosificación , Metotrexato/uso terapéutico , Óxido Nítrico/metabolismo , Radiografía , Ratas , Ratas Endogámicas Lew , Sesquiterpenos/administración & dosificación , Factores de Tiempo
8.
Br J Pharmacol ; 148(5): 688-95, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16702985

RESUMEN

1. The present study evaluated the participation of tumour necrosis factor-alpha (TNF-alpha) in the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. 2. The intraplantar injection of carrageenan (300 microg paw-1) induced a marked and biphasic paw oedema formation (peaks at 6 and 72 h), which was accompanied by a long-lasting mechanical allodynia (that remained elevated for up to 72 h) and a significant increase of myeloperoxidase (MPO) activity (peak at 6 h) in both Swiss and C57/BL6 mice. 3. The paw oedema, the elevation of MPO activity and to a lesser extent the mechanical allodynia elicited by carrageenan were found to be significantly reduced in TNF-alpha p55 receptor knockout mice. 4. Of interest, the systemic administration of an anti-TNF-alpha antibody produced a significant inhibition of paw oedema, mechanical allodynia and MPO activity. A noteworthy decrease in inflammatory and nociceptive responses caused by carrageenan was also observed when mice were previously treated with the preferential inhibitor of TNF-alpha synthesis, thalidomide. 5. The present results clearly indicate that the proinflammatory cytokine TNF-alpha plays a critical role in the oedema formation, as well as in the mechanical allodynia and the neutrophil migration, following carrageenan administration into the mouse paw. Intraplantar injection of carrageenan in mice could constitute a useful model for assessment of the in vivo effects of potential inhibitors of TNF-alpha-related pathways.


Asunto(s)
Carragenina/farmacología , Traumatismos de los Pies/inducido químicamente , Inflamación/inducido químicamente , Dimensión del Dolor/efectos de los fármacos , Factor de Necrosis Tumoral alfa/fisiología , Animales , Edema/inducido químicamente , Pie/fisiología , Enfermedades del Pie/inducido químicamente , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Dolor/inducido químicamente , Peroxidasa/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo
11.
Contact Dermatitis ; 45(2): 68-71, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11553114

RESUMEN

We review the literature on cement burns of the skin published during the last 4 decades. 51 case reports were analyzed with special regard to common modes of injury, localization of cement exposure, preventive measures taken and treatment. Cement burns are injuries concerning professionals at the workplace as well as amateurs during do-it-yourself work. In 49% of the cases, no attempt to protect the skin had been made. The majority of injuries were located on the lower legs and knees. Full-thickness burns were reported in 66% of cases. Surgery had to be performed in 34%. Cement burns can be avoided by adequate skin protection. Although acute cement injuries may seem rare, prospective studies should be carried out for correct estimation of prevalence. The need for information on the harmful properties of cement in the occupational as well as the domestic environment is emphasized.


Asunto(s)
Quemaduras Químicas/epidemiología , Quemaduras Químicas/etiología , Cáusticos/efectos adversos , Materiales de Construcción/efectos adversos , Enfermedades Profesionales/epidemiología , Enfermedades Profesionales/etiología , Piel/lesiones , Adulto , Quemaduras Químicas/patología , Quemaduras Químicas/prevención & control , Quemaduras Químicas/cirugía , Cáusticos/química , Femenino , Traumatismos de los Pies/inducido químicamente , Traumatismos de los Pies/epidemiología , Alemania/epidemiología , Humanos , Puntaje de Gravedad del Traumatismo , Traumatismos de la Pierna/inducido químicamente , Traumatismos de la Pierna/epidemiología , Masculino , Enfermedades Profesionales/patología , Enfermedades Profesionales/prevención & control , Enfermedades Profesionales/cirugía , Ropa de Protección , Trasplante de Piel
13.
J Accid Emerg Med ; 14(6): 401-2, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9413783

RESUMEN

An effective method of providing pain relief in hydrofluoric acid burns is reported, using a Bier's block type technique and regional intravenous calcium gluconate. This method allows satisfactory analgesia and prevents further tissue destruction, without the risk and added discomfort of increased tissue tensions associated with local infiltration of calcium.


Asunto(s)
Quemaduras Químicas/tratamiento farmacológico , Gluconato de Calcio/uso terapéutico , Ácido Fluorhídrico , Adulto , Femenino , Traumatismos de los Dedos/inducido químicamente , Traumatismos de los Pies/inducido químicamente , Humanos , Masculino , Bloqueo Nervioso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...